Adel A. Yafarova

Moscow, MOW 101990, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Fatigue in Metabolic Dysfunction-Associated Steatotic Liver Disease: Links to Muscle Function, Hypoxia, and Hypertension.

Fatigue in Metabolic Dysfunction-Associated Steatotic Liver Disease: Links to Muscle Function, Hypoxia, and Hypertension.

Journal: Healthcare (Basel, Switzerland)

Published: July 21, 2025

Gut Microbiota and Metabolic Alterations Associated with Heart Failure and Coronary Artery Disease.

Gut Microbiota and Metabolic Alterations Associated with Heart Failure and Coronary Artery Disease.

Journal: International journal of molecular sciences

Published: September 03, 2024

Bioelectrical Impedance Analysis Demonstrates Reliable Agreement with Dual-Energy X-ray Absorptiometry in Identifying Reduced Skeletal Muscle Mass in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Hypertension.

Bioelectrical Impedance Analysis Demonstrates Reliable Agreement with Dual-Energy X-ray Absorptiometry in Identifying Reduced Skeletal Muscle Mass in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Hypertension.

Journal: Diagnostics (Basel, Switzerland)

Published: August 18, 2024

Sonographic Features of Rectus Femoris Muscle in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Their Correlation with Body Composition Parameters and Muscle Strength: Results of a Single-Center Cross-Sectional Study.

Sonographic Features of Rectus Femoris Muscle in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Their Correlation with Body Composition Parameters and Muscle Strength: Results of a Single-Center Cross-Sectional Study.

Journal: Biomedicines

Published: June 18, 2024

Gut Microbiota Patterns in Patients with Non-Alcoholic Fatty Liver Disease: A Comprehensive Assessment Using Three Analysis Methods.

Gut Microbiota Patterns in Patients with Non-Alcoholic Fatty Liver Disease: A Comprehensive Assessment Using Three Analysis Methods.

Journal: International journal of molecular sciences

Published: August 17, 2023

Clinically Meaningful Fatigue and Depression Are Associated with Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease.

Clinically Meaningful Fatigue and Depression Are Associated with Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease.

Journal: Journal of personalized medicine

Published: April 10, 2023

Diversities in the Gut Microbial Patterns in Patients with Atherosclerotic Cardiovascular Diseases and Certain Heart Failure Phenotypes.

Diversities in the Gut Microbial Patterns in Patients with Atherosclerotic Cardiovascular Diseases and Certain Heart Failure Phenotypes.

Journal: Biomedicines

Published: October 11, 2022

Reduced Quality of Life in Patients with Non-Alcoholic Fatty Liver Disease May Be Associated with Depression and Fatigue.

Reduced Quality of Life in Patients with Non-Alcoholic Fatty Liver Disease May Be Associated with Depression and Fatigue.

Journal: Healthcare (Basel, Switzerland)

Published: July 12, 2022

Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives.

Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives.

Journal: Biomedicines

Published: July 12, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026